NCT02800317 - RISAS Procedure in Node Positive Breast Cancer Following NAC | Biotech Hunter

Enrollment

248

Participants

Timeline

Start Date

March 30, 2017

Primary Completion Date

July 1, 2020

Study Completion Date

December 3, 2021

Conditions

Breast NeoplasmNeoadjuvant TherapyAxillary Lymph NodesPathological Complete Response

Interventions

PROCEDURE

RISAS

RISAS procedure contains Radioactive Iodine Seed localisation in the Axilla in axillary node positive breast cancer combined with a Sentinel node procedure.

Trial Locations (14)

Unknown

Wilhelmina Hospital, Assen

Amphia Hospital, Breda

Albert Schweitzer Hospital, Dordrecht

Martini Hospital, Groningen

Zuyderland Medical Center, Heerlen

Hospital Group Twente, Hengelo

Treant, Hoogeveen

Maastricht University Medical Center, Maastricht

Bravis Hospital, Roosendaal

Erasmus Medical Center, Rotterdam

Ikazia Hospital, Rotterdam

Maasstad Hospital, Rotterdam

Franciscus Gasthuis & Vlietland, Schiedam

University Medical Center Utrecht, Utrecht